You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Excessive Daytime Sleepiness

Showing 1 - 25 of 3,968
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sleep Deprivation Trial in Bordeaux (Total sleep deprivation, Normal sleep)

Recruiting
  • Sleep Deprivation
  • Total sleep deprivation
  • Normal sleep
  • Bordeaux, France
    CHU de Bordeaux
Nov 25, 2022

Obstructive Sleep Apnea Syndrome With Residual Excessive Daytime

Recruiting
  • Sleep Apnea Syndromes
  • Treatment
  • Oggebbio, Italy
    Istituto Auxologico Italiano
Mar 21, 2023

Prader-Willi Syndrome, Excessive Daytime Sleepiness, Hyperphagia Trial in Brooklyn (Sham Light, Bright Light Therapy)

Not yet recruiting
  • Prader-Willi Syndrome
  • +5 more
  • Sham Light
  • Bright Light Therapy
  • Brooklyn, New York
    Maimonides Medical Center
Jul 2, 2023

Alternative Epworth Sleepiness Scale ESS-ALT in French

Not yet recruiting
  • Excessive Daytime Sleepiness
  • Test of an alternative Epworth Sleepiness Scale ESS-ALT in French
  • Ivry-sur-Seine, France
    Hospital Charles Foix
Apr 7, 2023

Excessive Daytime Sleepiness Trial (Pitolisant, Placebo oral tablet)

Recruiting
  • Excessive Daytime Sleepiness
  • Beijing, China
    Tsinghua Changgung Hospital
Oct 17, 2022

Delphi Consensus Excessive Daytime Sleepiness in OSA

Active, not recruiting
  • Obstructive Sleep Apnea
    • London, United Kingdom
      King's College London
    Mar 28, 2022

    Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea Trial in China (Solriamfetol, Placebo)

    Recruiting
    • Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea
    • ShangHai, Shanghai, China
    • +25 more
    Oct 26, 2023

    Myotonic Dystrophy 1, Excessive Daytime Sleepiness Trial in Canada, United States (Pitolisant Oral Tablet, Placebo oral tablet)

    Recruiting
    • Myotonic Dystrophy 1
    • Excessive Daytime Sleepiness
    • Pitolisant Oral Tablet
    • Placebo oral tablet
    • Irvine, California
    • +16 more
    Aug 24, 2022

    Narcolepsy, Cataplexy, Excessive Daytime Sleepiness Trial in Canada, United States (AXS-12 (reboxetine), Placebo)

    Enrolling by invitation
    • Narcolepsy
    • +2 more
    • AXS-12 (reboxetine)
    • Placebo
    • Santa Ana, California
    • +18 more
    Sep 23, 2022

    Sleep Trial in Mersin (Acupressure, Plasebo acupressure)

    Completed
    • Sleep
    • Acupressure
    • Plasebo acupressure
    • Mersin, Yenişehir, Turkey
      Mersin University
    Nov 7, 2022

    Sleepiness, Fatigue, Feeding Patterns Trial in Nicosia, Trikala (Evening LGI Carbohydrate Consumption Group, Evening HGI

    Recruiting
    • Sleepiness
    • +3 more
    • Evening LGI Carbohydrate Consumption Group
    • +2 more
    • Nicosia, Cyprus
    • +1 more
    Jul 14, 2022

    Parkinson Disease, Excessive Daytime Somnolence Trial (Valiloxybate, Placebo)

    Not yet recruiting
    • Parkinson Disease
    • Excessive Daytime Somnolence
    • (no location specified)
    Sep 17, 2021

    Parkinson Disease Trial in China (Selegiline)

    Completed
    • Parkinson Disease
    • Changshu, Jiangsu, China
    • +3 more
    May 5, 2021

    Narcolepsy Trial in United States (ADX-N05, Placebo)

    Completed
    Has Results
    • Narcolepsy
    • Phoenix, Arizona
    • +9 more
    Jun 11, 2021

    Excessive Daytime Sleepiness, Parkinson Disease Trial in Miami (BEN-2001, Placebo)

    Completed
    Has Results
    • Excessive Daytime Sleepiness
    • Parkinson Disease
    • Miami, Florida
      MaxBlue Institute
    Nov 3, 2020

    Narcolepsy, Cataplexy, Excessive Daytime Sleepiness Trial in Canada, United States (AXS-12 (reboxetine), Placebo)

    Recruiting
    • Narcolepsy
    • +2 more
    • AXS-12 (reboxetine)
    • Placebo
    • Alabaster, Alabama
    • +45 more
    Sep 23, 2022

    Excessive Daytime Sleepiness, Cataplexy, Narcolepsy Trial in Worldwide (FT218, Placebo)

    Completed
    Has Results
    • Excessive Daytime Sleepiness
    • +2 more
    • Anniston, Alabama
    • +56 more
    Mar 18, 2022

    Excessive Daytime Somnolence, Obstructive Sleep Apnea Trial in Worldwide (Solriamfetol, Placebo)

    Active, not recruiting
    • Excessive Daytime Somnolence
    • Obstructive Sleep Apnea
    • Los Angeles, California
    • +27 more
    May 31, 2022

    Sleepiness, Daytime, Fatigue, Sleep Disorders, Circadian Rhythm Trial in Trikala (Lifestyle Medicine Strategies)

    Recruiting
    • Sleepiness, Daytime
    • +2 more
    • Lifestyle Medicine Strategies
    • Trikala, Thessaly, Greece
      Lifestlye Medicine Laboratory, TEFAA, University of Thessaly
    Oct 14, 2021

    Sleepiness, Daytime Trial in Belmont (LED bright light treatment device)

    Completed
    • Sleepiness, Daytime
    • LED bright light treatment device
    • Belmont, Massachusetts
      McLean Hospital
    May 16, 2022

    Narcolepsy Trial in United States (ADX-N05, Placebo)

    Completed
    Has Results
    • Narcolepsy
    • Birmingham, Alabama
    • +27 more
    May 27, 2021

    Narcolepsy, Excessive Daytime Sleepiness, Cataplexy Narcolepsy Trial in United States (mazindol extended release, Placebo)

    Completed
    • Narcolepsy
    • +2 more
    • mazindol extended release
    • Placebo
    • Birmingham, Alabama
    • +21 more
    Aug 11, 2022

    Excessive Daytime Sleepiness, Obstructive Sleep Apnea Trial in Bulgaria, North Macedonia (Pitolisant (BF2.649), Placebo)

    Completed
    • Excessive Daytime Sleepiness
    • Obstructive Sleep Apnea
    • Pitolisant (BF2.649)
    • Placebo
    • Burgas, Bulgaria
    • +5 more
    Jul 7, 2020

    Daytime Sleepiness Trial in Tucson (Track 1, Track 2)

    Completed
    • Daytime Sleepiness
    • Track 1
    • Track 2
    • Tucson, Arizona
      University of Arizona Department of Psychiatry Research Faciliti
    Dec 17, 2020

    Excessive Sleepiness, Shift-work Disorder Trial in Boston (Solriamfetol Oral Tablet, Placebo)

    Recruiting
    • Excessive Sleepiness
    • Shift-work Disorder
    • Solriamfetol Oral Tablet
    • Placebo
    • Boston, Massachusetts
      Brigham and Women's Hospital
    May 23, 2022